Aziz Ahmed Ali, Aziz Muhammad Ali, Zahid Rida, Amir Muhammad, Shah Rehan, Ali Ijlal Akbar
Internal Medicine, INTEGRIS Health Baptist Medical Center, Oklahoma City, USA.
Internal Medicine, University of Kentucky College of Medicine, Lexington, USA.
Cureus. 2025 Jun 27;17(6):e86875. doi: 10.7759/cureus.86875. eCollection 2025 Jun.
Primary hepatic angiosarcoma (PHA) is a rare malignant tumor of the liver with an extremely poor prognosis even after diagnosis and treatment. It is difficult to diagnose due to a lack of disease-specific clinical features, tumor markers, or imaging findings. Due to its rarity of occurrence, treatment protocols are not yet clear. We present a rare case of PHA in a 39-year-old female who presented with right upper quadrant abdominal pain and was found to have acute liver failure and a non-resectable liver mass. She underwent a liver transplant (LT) as PHA could not be diagnosed before the transplant. She received chemotherapy and had done well for 12 months until her carcinoma relapsed. She underwent a repeat cycle of chemotherapy; however, her tumor continued to progress and is now undergoing a trial of immunotherapy.
原发性肝血管肉瘤(PHA)是一种罕见的肝脏恶性肿瘤,即便经过诊断和治疗,其预后仍极差。由于缺乏疾病特异性的临床特征、肿瘤标志物或影像学表现,该病难以诊断。因其发病率低,治疗方案尚不明确。我们报告一例罕见的PHA病例,患者为一名39岁女性,表现为右上腹疼痛,被发现患有急性肝衰竭和不可切除的肝脏肿块。由于在移植前无法诊断出PHA,她接受了肝移植(LT)。她接受了化疗,在12个月内情况良好,直到癌症复发。她接受了重复化疗周期;然而,她的肿瘤持续进展,目前正在接受免疫治疗试验。